Non-alcoholic greasy liver disease is the most widely recognized ongoing liver illness on the planet. In its high-level structure, non-alcoholic steatohepatitis (NASH) is reparable when analyzed and treated in its beginning phases. Notwithstanding, when left untreated, it could advance to the irreversible phase of liver cirrhosis and malignant growth, making early analysis basic. Nevertheless, until now, the main way to conclusively analyze NASH was through a liver biopsy, which is frequently difficult and obtrusive to patients. This demonstrates the earnest need to foster better indicative methodologies for NASH. To handle this issue, colleague Teacher Wang Jiong-Wei from the Branch of